Aims This study aimed to assess the impact of different antidiabetic agents on individuals
with diabetes and COVID-19. Methods We searched PubMed, Web of Science, Embase …

Importance Patients with COVID-19 have a high prevalence of diabetes, and diabetes and
blood glucose control are determinants of intensive care unit admission and mortality …

Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …

Patients with type-2 diabetes (T2D) are more likely to develop severe respiratory tract
infections. Such susceptibility has gained increasing attention since the global spread of …

The aim To study the association of demographic, clinical, and laboratory factors and the
use of glucose-lowering drugs and anti-coronavirus disease (COVID-19) vaccination with …

С декабря 2019 г. в мире активно распространяется опасное вирусное заболевание-
COVID-19, вызванное новым РНК-коронавирусом SARS-COV-2. Основным …

Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and
prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values …

Metformin (MTF) occupies a major and fundamental position in the therapeutic management
of type 2 diabetes mellitus (T2DM). Gender differences in some effects and actions of MTF …

Background Patients with diabetes are more likely to suffer COVID‐19 complications. Using
noninsulin antihyperglycemic medications (AGMs) during COVID‐19 infection has proved …

A dangerous viral disease COVID-19, caused by a new RNA coronavirus SARS-COV-2, has
been actively spreading in the world since December 2019. The main manifestations of this …